Acetohydroxamic acid , 98% , 546-88-3
Synonym(s):
AHA
CAS NO.:546-88-3
Empirical Formula: C2H5NO2
Molecular Weight: 75.07
MDL number: MFCD00009994
EINECS: 208-913-8
Pack Size | Price | Stock | Quantity |
1G | RMB23.20 | In Stock |
|
5G | RMB48.80 | In Stock |
|
25G | RMB108.80 | In Stock |
|
100G | RMB335.20 | In Stock |
|
500g | RMB1339.20 | In Stock |
|
others | Enquire |
PRODUCT Properties
Melting point: | 88-90 °C (lit.) |
Boiling point: | 133.7°C (rough estimate) |
Density | 1.2269 (rough estimate) |
refractive index | 1.4264 (estimate) |
storage temp. | Keep in dark place,Inert atmosphere,Room temperature |
solubility | Methanol (Sparingly), Water (Sparingly) |
form | Crystalline Solid |
pka | 8.70(at 25℃) |
color | White to pale yellow |
Water Solubility | Soluble in water. |
Sensitive | Hygroscopic |
Merck | 14,63 |
BRN | 1739019 |
Stability: | Moisture and Temperature Sensitive |
InChIKey | RRUDCFGSUDOHDG-UHFFFAOYSA-N |
Description and Uses
Acetohydroxamic acid is a potent, non-competitive and irreversible inhibitor of bacterial urease (Ki≈lO-7M). This enzyme, which is widely distributed in plants and bacteria, but not in mammalian cells, catalyzes the decomposition of urea to ammonia. Elevated urinary ammonia levels can reduce the antibacterial effectiveness of a number of agents. Thus, acetohydroxamic acid is useful as adjunctive therapy to decrease urinary ammonia and alkalinity in patients with chronic urea-splitting urinary infection. Such infections are a leading cause of recurring complications and death in paraplegics.
A urease inhibitor. Used in the synthesis
Safety
Symbol(GHS) | GHS08 |
Signal word | Danger |
Hazard statements | H360 |
Precautionary statements | P201-P280-P308+P313 |
Hazard Codes | T |
Risk Statements | 61-40 |
Safety Statements | 53-45-36/37/39-22 |
RIDADR | 3263 |
WGK Germany | 3 |
RTECS | AK8157000 |
Hazard Note | Toxic |
PackingGroup | II |
HS Code | 29225090 |
Toxicity | mmo-sat 160 mmol/plate JOPHDQ 3,557,80 |